[Risks of specific hyposensitization treatment].
In appropriate cases of diseases mediated by IgE, specific hyposensitization may be a successful way of treatment. According to prospective studies, the risk of side effects ranges between 0.1 and 1% per injection. We report on cases with fatal outcome and suggest suitable strategies in order to avoid serious complications.
Rakoski
J
J
Dermatologische Klinik und Poliklinik der Technischen Universität München.
D000707:Anaphylaxis / Q000401:mortality; D003888:Desensitization, Immunologic / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D007073:Immunoglobulin E / Q000096:biosynthesis*; D012130:Respiratory Hypersensitivity / Q000628:therapy; D012307:Risk Factors
D007073:Immunoglobulin E
Risiken der spezifischen Hyposensibilisierungsbehandlung.